title: Effect of Cu supplementation on genomic instability in chemically-induced mammary carcinogenesis in the rat.
abstract: BACKGROUND
  The aim of the present study was to assess the effect of dietary supplementation (copper or copper and resveratrol) on the intensity of carcinogenesis and the frequency of microsatellite instability in a widely used model of mammary carcinogenesis induced in the rat by treatment with 7,12-dimethylbenz[a]anthracene (DMBA).
  
  
  METHODS
  DNA was extracted from rat mammary cancers and normal tisues, amplified by PCR, using different polymorphic DNA markers and the reaction products were analyzed for microsatellite instability.
  
  
  RESULTS
  It was found that irrespectively of the applied diet there was no inhibition of mammary carcinogenesis in the rats due to DMBA. Besides, in the groups supplemented with Cu (II) or Cu (II) and resveratrol the tumor formation was clearly accelerated. Unlike the animals that were fed with standard diet, the supplemented rats were characterized by the loss of heterozygosity of microsatellite D3Mgh9 in cancer tumors (by respectively 50 and 40%). When the animals received Cu (II) and resveratrol supplemented diet the occurrence of genomic instability was additionally found in their livers in the case of microsatellite D1Mgh6 (which was stable in the animals without dietary supplementation).
  
  
  CONCLUSIONS
  Identification of the underlying mechanisms by which dietary factors affect genomic stability might prove useful in the treatment of mammary cancer as well as in the incorporation of dietary factors into mammary cancer prevention strategies.
authors.affiliation: Department of Bromatology, Medical University of Warsaw, Poland, Banacha 1, 02-097 Warsaw. barbara.bobrowska@wum.edu.pl
authors.forename: Barbara
authors.initials: B
authors.lastname: Bobrowska
authors.forename: Dorota
authors.initials: D
authors.lastname: Skrajnowska
authors.forename: Andrzej
authors.initials: A
authors.lastname: Tokarz
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic; D003300:Copper / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D005260:Female; D042822:Genomic Instability; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000235:genetics* / Q000517:prevention & control; D018895:Microsatellite Repeats; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077185:Resveratrol; D013267:Stilbenes / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D016588:Anticarcinogenic Agents; D013267:Stilbenes; D015127:9,10-Dimethyl-1,2-benzanthracene; D003300:Copper; D000077185:Resveratrol